您的位置: 首页 > 农业专利 > 详情页

THERAPEUTIC USES OF GLANDULAR KALLIKREIN
专利权人:
DiaMedica Inc.
发明人:
Istvan Berczi,Mark S. Williams
申请号:
US13666669
公开号:
US20130224230A1
申请日:
2012.11.01
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention relates to pharmaceutical compositions comprising glandular kallikrein in combination with myelin basic protein or copaxone for use in the treatment of multiple sclerosis. The present invention further relates to a method of suppressing autoimmune responses in a patient afflicted with or suffering at least one clinical sign of multiple sclerosis, comprising administering to said patient a therapeutically effective amount of glandular kallikrein in combination with a therapeutically effective amount of myelin basic protein or copaxone.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充